ENDO 2025 featured the latest research on novel therapies for adrenal and neuroendocrine conditions, new data on various ...

Novo Nordisk has said a real-world survey of its weight-loss therapy Wegovy shows it can reduce 'food noise', persistent, ...

Novo Nordisk’s injectable amylin alternative to Wegovy appears to have underperformed the approved obesity blockbuster in a ...

A large Cleveland Clinic study has found that people with obesity and type 2 diabetes who undergo weight-loss surgery live ...

The new FDA program is "a perfect fit" for Lilly's pill, according to Citi Research analyst Geoffrey Meacham. The FDA, which ...

Serena Williams is noticeably slimmer now than she was when she retired from the WTA Tour in 2022. Last month she revealed how that happened.

Eli Lilly 's experimental weight-loss pill could be fast-tracked under a one- to two-month review process recently launched ...

Delayed gastric emptying, potential aspiration risks, and medication interactions — learn the hospitalist’s approach to ...

A large Cleveland Clinic study has found that people with obesity and type 2 diabetes who undergo weight-loss surgery live longer and face fewer serious health problems compared with those treated ...

In a landmark shift, the World Health Organisation (WHO) has recommended the inclusion of GLP-1 drugs as part of long-term ...

A new study led by investigators at Mass General Brigham finds that adding novel weight loss GLP-1 drugs semaglutide and tirzepatide to usual care represents a cost-effective treatment strategy for ...